按瑞典旧诊断标准或世界卫生组织新诊断标准分类的妊娠糖尿病两年后的葡萄糖耐量。

IF 6.1 3区 医学 Q1 ENDOCRINOLOGY & METABOLISM
{"title":"按瑞典旧诊断标准或世界卫生组织新诊断标准分类的妊娠糖尿病两年后的葡萄糖耐量。","authors":"","doi":"10.1016/j.diabres.2024.111831","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><p>To explore how introduction of the lower WHO gestational diabetes (GDM) glucose criteria in Sweden affected prediabetes/type-2-diabetes (T2D) incidence two years postpartum.</p></div><div><h3>Methods</h3><p>Women included in the PREvention of PostPartum (PREPP) diabetes study were diagnosed with GDM according to EASD 1991 criteria (GDM<sub>OLD</sub>; n = 93) or only WHO 2013 criteria (GDM<sub>WHO</sub>; n = 174). Both groups were further stratified by BMI, and BMI-matched normoglycemic pregnancy controls were included (n = 88). Postpartum assessments included oral glucose tolerance tests (OGTT) and anthropometric measurements.</p></div><div><h3>Results</h3><p>There was a higher postpartum incidence of T2D in GDM<sub>OLD</sub> versus GDM<sub>WHO</sub> (P &lt; 0.001). Despite similar BMI, GDM<sub>OLD</sub> exhibited higher fasting and OGTT glucose levels, lower fat-free-mass, and hip circumference compared to GDM<sub>WHO</sub>. In normal-weight women, both GDM groups displayed higher HOMA-IR and lower fat-free-mass compared to controls, with GDM<sub>OLD</sub> additionally showing lower HOMA-β, slower insulin release during OGTT, and worse glucose tolerance than GDM<sub>WHO</sub>. Among obese women, the main differences were lower fat-free-mass and hip circumference in GDM<sub>OLD</sub>.</p></div><div><h3>Conclusion</h3><p>The lower glucose cut-offs during pregnancy resulted in lower postpartum incidence of T2D, irrespective of BMI. Fat-free-mass emerged as a key determinant in glucose levels across BMI categories, while lower beta-cell function played a significant role in normal-weight women.</p></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":null,"pages":null},"PeriodicalIF":6.1000,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0168822724007411/pdfft?md5=b82e0306a5c05a17e358b73793a57526&pid=1-s2.0-S0168822724007411-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Glucose tolerance two years after gestational diabetes classified by old Swedish or new WHO diagnostic criteria\",\"authors\":\"\",\"doi\":\"10.1016/j.diabres.2024.111831\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aim</h3><p>To explore how introduction of the lower WHO gestational diabetes (GDM) glucose criteria in Sweden affected prediabetes/type-2-diabetes (T2D) incidence two years postpartum.</p></div><div><h3>Methods</h3><p>Women included in the PREvention of PostPartum (PREPP) diabetes study were diagnosed with GDM according to EASD 1991 criteria (GDM<sub>OLD</sub>; n = 93) or only WHO 2013 criteria (GDM<sub>WHO</sub>; n = 174). Both groups were further stratified by BMI, and BMI-matched normoglycemic pregnancy controls were included (n = 88). Postpartum assessments included oral glucose tolerance tests (OGTT) and anthropometric measurements.</p></div><div><h3>Results</h3><p>There was a higher postpartum incidence of T2D in GDM<sub>OLD</sub> versus GDM<sub>WHO</sub> (P &lt; 0.001). Despite similar BMI, GDM<sub>OLD</sub> exhibited higher fasting and OGTT glucose levels, lower fat-free-mass, and hip circumference compared to GDM<sub>WHO</sub>. In normal-weight women, both GDM groups displayed higher HOMA-IR and lower fat-free-mass compared to controls, with GDM<sub>OLD</sub> additionally showing lower HOMA-β, slower insulin release during OGTT, and worse glucose tolerance than GDM<sub>WHO</sub>. Among obese women, the main differences were lower fat-free-mass and hip circumference in GDM<sub>OLD</sub>.</p></div><div><h3>Conclusion</h3><p>The lower glucose cut-offs during pregnancy resulted in lower postpartum incidence of T2D, irrespective of BMI. Fat-free-mass emerged as a key determinant in glucose levels across BMI categories, while lower beta-cell function played a significant role in normal-weight women.</p></div>\",\"PeriodicalId\":11249,\"journal\":{\"name\":\"Diabetes research and clinical practice\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2024-08-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0168822724007411/pdfft?md5=b82e0306a5c05a17e358b73793a57526&pid=1-s2.0-S0168822724007411-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes research and clinical practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0168822724007411\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822724007411","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:探讨瑞典采用较低的世卫组织妊娠糖尿病(GDM)血糖标准对产后两年的糖尿病前期/2型糖尿病(T2D)发病率有何影响:产后糖尿病预防(PREPP)研究中的妇女根据 EASD 1991 标准(GDMOLD;n = 93)或仅根据 WHO 2013 标准(GDMWHO;n = 174)被诊断为 GDM。两组均按体重指数进一步分层,并纳入与体重指数匹配的正常血糖妊娠对照组(n = 88)。产后评估包括口服葡萄糖耐量试验(OGTT)和人体测量:结果:与 GDMWHO 相比,GDMOLD 产后 T2D 发生率更高(P < 0.001)。尽管体重指数相似,但与 GDMWHO 相比,GDMOLD 的空腹血糖和 OGTT 血糖水平更高,脂肪重量和臀围更低。在体重正常的女性中,与对照组相比,两组 GDM 均表现出较高的 HOMA-IR 和较低的游离脂肪量,其中 GDMOLD 还表现出较低的 HOMA-β、OGTT 期间较慢的胰岛素释放速度以及比 GDMWHO 更差的葡萄糖耐量。在肥胖妇女中,GDMOLD 的主要差异是脂肪重量和臀围较低:结论:无论体重指数如何,孕期血糖临界值越低,产后 T2D 的发病率越低。在不同体重指数的妇女中,无脂肪体重是决定血糖水平的关键因素,而β细胞功能较低则在正常体重妇女中起着重要作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Glucose tolerance two years after gestational diabetes classified by old Swedish or new WHO diagnostic criteria

Aim

To explore how introduction of the lower WHO gestational diabetes (GDM) glucose criteria in Sweden affected prediabetes/type-2-diabetes (T2D) incidence two years postpartum.

Methods

Women included in the PREvention of PostPartum (PREPP) diabetes study were diagnosed with GDM according to EASD 1991 criteria (GDMOLD; n = 93) or only WHO 2013 criteria (GDMWHO; n = 174). Both groups were further stratified by BMI, and BMI-matched normoglycemic pregnancy controls were included (n = 88). Postpartum assessments included oral glucose tolerance tests (OGTT) and anthropometric measurements.

Results

There was a higher postpartum incidence of T2D in GDMOLD versus GDMWHO (P < 0.001). Despite similar BMI, GDMOLD exhibited higher fasting and OGTT glucose levels, lower fat-free-mass, and hip circumference compared to GDMWHO. In normal-weight women, both GDM groups displayed higher HOMA-IR and lower fat-free-mass compared to controls, with GDMOLD additionally showing lower HOMA-β, slower insulin release during OGTT, and worse glucose tolerance than GDMWHO. Among obese women, the main differences were lower fat-free-mass and hip circumference in GDMOLD.

Conclusion

The lower glucose cut-offs during pregnancy resulted in lower postpartum incidence of T2D, irrespective of BMI. Fat-free-mass emerged as a key determinant in glucose levels across BMI categories, while lower beta-cell function played a significant role in normal-weight women.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes research and clinical practice
Diabetes research and clinical practice 医学-内分泌学与代谢
CiteScore
10.30
自引率
3.90%
发文量
862
审稿时长
32 days
期刊介绍: Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信